The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

Braccini, G; Festini, F; Boni, V; Neri, A S; Galici, V; Campana, S; Zavataro, L; Trevisan, F; Braggion, C; Taccetti, G

Braccini, G; Festini, F; Boni, V; Neri, A S; Galici, V; Campana, S; Zavataro, L; Trevisan, F; Braggion, C; Taccetti, G.

Affiliation

Braccini G; Department of Pediatrics, University of Florence, Italy.

J Chemother ; 21(2): 188-92, 2009 Apr.

Article in En | MEDLINE | ID: mdl-19423472

Subject(s)

Anti-Bacterial Agents/economics; Cost of Illness; Cystic Fibrosis/drug therapy; Cystic Fibrosis/economics; Pseudomonas Infections/drug therapy; Pseudomonas Infections/economics; Adult; Anti-Bacterial Agents/therapeutic use; Ceftazidime/economics; Ceftazidime/therapeutic use; Child, Preschool; Chronic Disease; Ciprofloxacin/economics; Ciprofloxacin/therapeutic use; Clavulanic Acids/economics; Clavulanic Acids/therapeutic use; Colistin/economics; Colistin/therapeutic use; Cystic Fibrosis/complications; Humans; Meropenem; Pseudomonas Infections/etiology; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins/economics; Thienamycins/therapeutic use; Ticarcillin/economics; Ticarcillin/therapeutic use; Tobramycin/economics; Tobramycin/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Pseudomonas Infections / Cost of Illness / Cystic Fibrosis / Anti-Bacterial Agents Type of study: Etiology_studies / Health_economic_evaluation / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Child, preschool / Humans Language: En Journal: J Chemother Year: 2009 Document type: Article

Search on Google

XML

PubMed Links